BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 37494614)

  • 1. Fatal Severe Cytokine Release Syndrome Post-haploidentical Stem Cell Transplant With Post-transplant Cyclophosphamide in an Infant With Severe Combined Immunodeficiency and Disseminated Bacille Calmette-Guérin Infection.
    Arora S; Upasana K; Thakkar D; Yadav A; Rastogi N; Yadav SP
    J Pediatr Hematol Oncol; 2023 Aug; 45(6):e773-e774. PubMed ID: 37494614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine release syndrome after allogeneic stem cell transplantation with posttransplant cyclophosphamide.
    Solán L; Landete E; Bailén R; Dorado N; Oarbeascoa G; Anguita J; Díez-Martín JL; Kwon M
    Hematol Oncol; 2020 Oct; 38(4):597-603. PubMed ID: 32592410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCG-Related Inflammatory Syndromes in Severe Combined Immunodeficiency After TCRαβ+/CD19+ Depleted HSCT.
    Laberko A; Yukhacheva D; Rodina Y; Abramov D; Konovalov D; Radygina S; Shelikhova L; Pershin D; Kadnikova O; Maschan M; Maschan A; Balashov D; Shcherbina A
    J Clin Immunol; 2020 May; 40(4):625-636. PubMed ID: 32377975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case Report: Immune reconstitution inflammatory syndrome after hematopoietic stem cell transplantation for severe combined immunodeficiency.
    Liu S; Huo F; Dai G; Wu J; Qin M; Mao H; Wang Q
    Front Immunol; 2022; 13():960749. PubMed ID: 36225916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacillus Calmette-Guerin (BCG) Vaccine-associated Complications in Immunodeficient Patients Following Stem Cell Transplantation.
    NaserEddin A; Dinur-Schejter Y; Shadur B; Zaidman I; Even-Or E; Averbuch D; Shamriz O; Tal Y; Shaag A; Warnatz K; Elpeleg O; Stepensky P
    J Clin Immunol; 2021 Jan; 41(1):147-162. PubMed ID: 33111199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel treatment of severe combined immunodeficiency utilizing ex-vivo T-cell depleted haploidentical hematopoietic stem cell transplantation and CD45RA+ depleted donor lymphocyte infusions.
    Brodszki N; Turkiewicz D; Toporski J; Truedsson L; Dykes J
    Orphanet J Rare Dis; 2016 Jan; 11():5. PubMed ID: 26768987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacille Calmette-Guerin (BCG) complications in children with severe combined immunodeficiency (SCID).
    Barkai G; Somech R; Stauber T; Barziali A; Greenberger S
    Infect Dis (Lond); 2019 Aug; 51(8):585-592. PubMed ID: 31204539
    [No Abstract]   [Full Text] [Related]  

  • 8. Tocilizumab for Cytokine Release Syndrome Management After Haploidentical Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis.
    Yao JM; Otoukesh S; Kim H; Yang D; Mokhtari S; Samara Y; Blackmon A; Arslan S; Agrawal V; Pourhassan H; Amanam I; Ball B; Koller P; Salhotra A; Becker P; Curtin P; Artz A; Aldoss I; Ali H; Stewart F; Smith E; Stein A; Marcucci G; Forman SJ; Nakamura R; Al Malki MM
    Transplant Cell Ther; 2023 Aug; 29(8):515.e1-515.e7. PubMed ID: 37182736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Fanconi Anemia: Improving Outcomes with Improved Supportive Care in India.
    Uppuluri R; Swaminathan VV; Ramanan KM; Meena S; Varla H; Ramakrishnan B; Jayakumar I; Raj R
    Biol Blood Marrow Transplant; 2020 Dec; 26(12):2292-2298. PubMed ID: 32835780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful engraftment of haploidentical stem cell transplant with post-transplantation cyclophosphamide in a patient with adenosine deaminase deficiency.
    Medina D; Aristizabal AM; Madroñero T; Perez P; Patiño Niño J; Olaya M
    Pediatr Transplant; 2021 Sep; 25(6):e13954. PubMed ID: 33374035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disseminated Bacillus Calmette-Guérin (BCG) infection following allogeneic hematopoietic stem cell transplant in a patient with Bare Lymphocyte Syndrome type II.
    Abu-Arja RF; Gonzalez BE; Jacobs MR; Cabral L; Egler R; Auletta J; Arnold J; Cooke KR
    Transpl Infect Dis; 2014 Oct; 16(5):830-7. PubMed ID: 24995715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early administration of cyclosporine may reduce the incidence of cytokine release syndrome after HLA-haploidentical hematopoietic stem-cell transplantation with post-transplant cyclophosphamide.
    Kurita N; Sakamoto T; Kato T; Kusakabe M; Yokoyama Y; Nishikii H; Sakata-Yanagimoto M; Obara N; Hasegawa Y; Chiba S
    Ann Hematol; 2021 May; 100(5):1295-1301. PubMed ID: 33580280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine Release Syndrome Following Peripheral Blood Stem Cell Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide.
    Otoukesh S; Elmariah H; Yang D; Clark MC; Siraj M; Ali H; Mogili K; Arslan S; Nishihori T; Nakamura R; Pidala J; Marcucci G; Forman SJ; Anasetti C; Al Malki MM; Bejanyan N
    Transplant Cell Ther; 2022 Feb; 28(2):111.e1-111.e8. PubMed ID: 34844022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk-adapted therapy for the management of cytokine release syndrome in children undergoing unmanipulated haploidentical stem cell transplantation.
    Jayakumar I; Uppuluri R; Lakshmanan C; Kumar Gowdhaman A; Vellaichamy Swaminathan V; Raj R
    Pediatr Transplant; 2021 Aug; 25(5):e13964. PubMed ID: 33370509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Primary Immune Deficiency Disorders in Children: Challenges and Outcome from a Tertiary Care Center in South India.
    Uppuluri R; Sivasankaran M; Patel S; Swaminathan VV; Ramanan KM; Ravichandran N; Ramakrishnan B; Jayakumar I; Vaidhyanathan L; Raj R
    J Clin Immunol; 2019 Feb; 39(2):182-187. PubMed ID: 30778805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Early Bacillus Calmette-Guerin Vaccination of Pediatric Severe Combined Immunodeficiency Patients on the Outcome of Hematopoietic Stem Cell Transplantation Using a Reduced-Intensity Conditioning Regimen.
    Jafari L; Hamidieh AA; Behfar M; Karamlou Y; Shamsipour M; Mohseni R; Farajifard H; Salajegheh P
    Transplant Cell Ther; 2023 Mar; 29(3):188.e1-188.e8. PubMed ID: 36539079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Umbilical cord blood transplantation in severe T-cell immunodeficiency disorders: two-year experience.
    Knutsen AP; Wall DA
    J Clin Immunol; 2000 Nov; 20(6):466-76. PubMed ID: 11202237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Outcomes of Hematopoietic Stem Cell Transplantation for ZAP70 Deficiency.
    Cuvelier GD; Rubin TS; Wall DA; Schroeder ML
    J Clin Immunol; 2016 Oct; 36(7):713-24. PubMed ID: 27438785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of tocilizumab treatment for cytokine release syndrome on the incidence of early blood stream infections after peripheral blood haploidentical hematopoietic cell transplantation.
    De Togni E; Wan F; Slade M; Plach K; Abboud R
    Leuk Lymphoma; 2022 Dec; 63(12):2975-2981. PubMed ID: 35848998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disseminated Bacille Calmette-Guérin disease as the initial presentation of X-linked severe combined immunodeficiency--a case report.
    Huang LH; Shyur SD; Weng JD; Shin-Chi ; Tzen CY; Huang FY
    Asian Pac J Allergy Immunol; 2005 Dec; 23(4):221-6. PubMed ID: 16572742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.